The Life Sciences and Health Care department is a specialized team of lawyers from various fields providing support to pharmaceutical companies, wholesalers, pharmacies and hospitals. We work closely with other departments: tax, labour law and M&A. This enables us to provide clients with comprehensive services both in day-to-day operations and in exceptional events such as transactions or crisis situations.
Pharmaceutical law
Pharmaceutical and medical law, what with the ever-changing regulatory environment, makes it difficult to run an industry enterprise without expert legal support. Our team has extensive experience in pharmaceutical law.
We provide legal advice, attending to obtainment of the requisite permits, representation before relevant authorities and ongoing legal advice.
Services for entities operating in the drug market:
- Wholesale permits, operation of pharmacies, product authorization
- Pharmacovigilance
- Advertising and sales support activities
- Distribution agreements and parallel import issues
- Reimbursement
- Clinical trials
- Protection of intellectual property and counteracting unfair competition
- Representation of clients in litigation and relations with state authorities
Services to medical entities:
- Ongoing legal advice in medical activities
- Relations with the creating entity and the Social Council
- Audit of medical records
- Contracting and subcontracting
- Public procurement
- Activities in proceedings before inspection authorities
- Representation in litigation with the National Health Fund
- Patient rights and patient claims at all stages of proceedings
The basic principle that unites our team is to build relationships based on respect and trust.
We have been advising entrepreneurs for 30 years, so we understand the nature of business and how to properly support it. We focus on efficiency, transparency and partnership.
Experience
Selected projects
- Advised Pure Biologics on the acquisition of US-based Dystrogen Gene Therapies from the private capital fund BioFund Capital Management LLC and JD Copilot LLC through a share exchange, the conversion into shares of debt owed to private investment firm ACRX Investments Limited, and a public offering of shares, with an aggregate issue price of PLN 213.5 million
- Advised CenterMed on the acquisition of NZOZ Partner, a healthcare provider operating three medical facilities in Kielce offering primary healthcare, outpatient specialist care and rehabilitation services
- Advised LUX MED on the acquisition of 100% of the shares in TMS Diagnostyka, a medical imaging company
- Advised the selling shareholders on the disposal of six Centrum Diagnostyczno-Lecznicze Barska medical facilities to the Unity Care network, backed by the private equity fund Enterprise Investors
- Advised CenterMed on the acquisition of the Avimed Group, a healthcare provider operating in the Silesia region
- Advised LUX MED on the acquisition of the Mental Path network of seven mental health centres operating in five cities across Poland
- Advised Bioceltix on two equity offerings with a total value of PLN 116 million, comprising a shareholder-led secondary public offering conducted through an accelerated bookbuilding (ABB) process and the issuance of two tranches of new shares funded with proceeds from the ABB
- Advised CenterMed on the acquisition of 100% of the shares in CenterMed Poznań, a multi-specialty medical centre
- Advised Bioceltix on the execution of an investment substitution agreement with VTU Engineering Polska for the development of a pharmaceutical manufacturing facility in Wrocław dedicated to veterinary advanced therapy medicinal products (ATMPs)
- Advised on the Polish law aspects of the acquisition of Smithstown Light Engineering Group, an Irish medical device manufacturer with operations in Poland, by private equity firm Graham Partners
- Advised the ArKa family foundation on the sale of a 75% stake in Centrum Medyczne Med-Gastr, a gastroenterology clinic, to private equity fund Tar Heel Capital
- Advised Maabarot Products Ltd. on the EUR 28 million sale of Laboratoria Natury sp. z o.o., a dietary supplements manufacturer, to Farmaceutici Procemsa S.p.A., a portfolio company of the private equity fund Investindustrial
News
& Insights
16.06.2026
GESSEL strengthens its position in the 2026 Rzeczpospolita Law Firm Ranking
GESSEL has been recognised in 11 practice areas in the 24th edition of the Rzeczpospolita Law Firm Ranking, achieving its strongest result to date. Th...
20.05.2026
GESSEL advised CenterMed on the acquisition of NZOZ Partner
GESSEL advised CenterMed, a Polish medical group developing a network of healthcare facilities, on the acquisition of NZOZ Partner sp. z o.o., a healthcare services prov...
21.04.2026
GESSEL advises Lux Med on acquisition of TMS Diagnostyka
GESSEL advised Lux Med sp. z o.o., a leading private healthcare provider in Poland, on the acquisition of 100% of the shares in TMS Diagnostyka sp. z o.o., a Poland base...
16.01.2026
GESSEL’s dedicated Healthcare M&A team advised on ten sectoral deals in 2025
In 2025, GESSEL successfully advised on ten mergers and acquisitions transactions in the healthcare sector. The mandates covered advisory services on both the sell side ...
15.01.2026
GESSEL advised CenterMed on the acquisition of the Avimed Group
GESSEL advised CenterMed, a Polish network of outpatient clinics and medical facilities operating in the healthcare services market, on the acquisition of the AVIMED Gro...
07.01.2026
GESSEL advised on the sale of Centrum Diagnostyczno Lecznicze Barska to Unity Care
GESSEL advised the selling shareholders on the sale of Centrum Diagnostyczno Lecznicze Barska sp. z o.o., a privately owned healthcare provider, to Unity Care sp. z o.o....
Contact us
